Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Do not take another gummy quickly because the first one feels delayed
Brand name Active drug Indication Approval year Max approved dose Ozempic Semaglutide Type 2 diabetes (glycemic control) 2017 2 mg/week Wegovy Semaglutide Chronic weight management (BMI 30 or 27 + comorbidity) 2021 2.4 mg/week Rybelsus Semaglutide Type 2 diabetes (oral daily tablet) 2019 14 mg/day (oral) Mounjaro Tirzepatide Type 2 diabetes (glycemic control) 2022 15 mg/week Zepbound Tirzepatide Chronic weight management (BMI 30 or 27 + comorbidity) 2023 15 mg/week Table 1 FDA-approved indications for semaglutide and tirzepatide brand names
In June 2025, Amgen reported robust results from its Phase2 clinical study of MariTide, a monthly injectable bispecific GLP-1/GIP receptor agonist
Verify the USP-797 compounding certification of pharmacies before purchasing the medication
Our team has guided hundreds of research protocols through peptide stacking sequences over the past decade
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
